Haleon plc (NYSE:HLN) Given Consensus Recommendation of “Buy” by Brokerages

Haleon plc (NYSE:HLN) has been assigned a consensus recommendation of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $10.95.

Several equities research analysts recently weighed in on HLN shares. UBS Group upgraded Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Morgan Stanley boosted their target price on shares of Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a report on Friday, September 20th. Berenberg Bank started coverage on shares of Haleon in a research note on Tuesday, August 6th. They issued a “buy” rating for the company. Finally, The Goldman Sachs Group lowered shares of Haleon from a “buy” rating to a “neutral” rating in a research note on Tuesday, August 6th.

Institutional Trading of Haleon

Institutional investors have recently modified their holdings of the company. FMR LLC increased its holdings in Haleon by 5.8% in the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock worth $1,110,035,000 after buying an additional 5,768,117 shares during the period. Clearbridge Investments LLC boosted its holdings in Haleon by 8.6% in the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock valued at $344,888,000 after purchasing an additional 3,307,009 shares during the last quarter. Wellington Management Group LLP grew its holdings in Haleon by 49.9% during the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock worth $96,833,000 after acquiring an additional 3,046,841 shares during the period. Sculptor Capital LP boosted its holdings in Haleon by 67.8% during the second quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock worth $73,407,000 after buying an additional 3,592,000 shares in the last quarter. Finally, Douglas Lane & Associates LLC increased its stake in shares of Haleon by 1.6% in the 2nd quarter. Douglas Lane & Associates LLC now owns 8,533,768 shares of the company’s stock valued at $70,489,000 after purchasing an additional 131,892 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors.

Haleon Trading Up 0.8 %

Shares of HLN stock opened at $9.56 on Friday. The firm has a market cap of $43.25 billion, a P/E ratio of 28.10, a PEG ratio of 2.86 and a beta of 0.30. Haleon has a 12-month low of $7.89 and a 12-month high of $10.80. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The company has a 50 day moving average of $10.03 and a 200-day moving average of $9.37.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.